SCHEMBL24834760

SCHEMBL24834760

O=C(O)c1c(Br)nn2c(=O)cc(-c3ccc(C4CCCCC4)cc3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
HSP90AA1 P07900 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
DHODH Q02127 2/20 0.38
PRKAB2 O43741 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA2 P54646 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAG3 Q9UGI9 1/20 0.37
PRKAG2 Q9UGJ0 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
S1PR1 P21453 4/20 0.36
ACMSD Q8TDX5 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24834869 0.88 GAA (0.39) KMT2ATDP1HSP90AA1GAAMAPT
SCHEMBL23415011 0.86 PLAT (0.42) KMT2ATDP1HSP90AA1GAAMAPT
SCHEMBL23415244 0.85 S1PR4 (0.37) DHODHS1PR1PLATS1PR4S1PR3
SCHEMBL29785725 0.85 S1PR4 (0.37) DHODHS1PR1PLATS1PR4S1PR3
SCHEMBL24834914 0.84 PLAT (0.34) DHODHPLAT
SCHEMBL23415000 0.84 CHEK2 (0.37) GAAPLATCYP3A4CYP2C9
SCHEMBL24834977 0.83 HSP90AA1 (0.35) KMT2ATDP1HSP90AA1GAAMAPT
SCHEMBL24834777 0.83 KMT2A (0.38) KMT2ATDP1HSP90AA1GAAMAPT
SCHEMBL24834868 0.82 DHODH (0.38) KMT2ATDP1HSP90AA1GAAMAPT
SCHEMBL24834839 0.81 PLAT (0.47) KMT2ATDP1HSP90AA1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002396-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2023-01-05 US disclosed
EP-4065230-A1 THERAPEUTIC COMPOUNDS Genentech, Inc. (US) 2022-10-05 EP disclosed
CN-114786778-A Therapeutic compounds 基因泰克公司 2022-07-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002396-A1 THERAPEUTIC COMPOUNDS YAP1, YES1, TEAD2 KMT2A 3482/4885TDP1 2068/4885HSP90AA1 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.